As of November 2024, Rohto Pharmaceutical has a market cap of $5.57B. This makes Rohto Pharmaceutical the world's 2561th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.60B | 1.25% |
2023 | $4.55B | 22.54% |
2022 | $3.71B | -33.24% |
2021 | $5.56B | 13.75% |
2020 | $4.89B | -7.98% |
2019 | $5.31B | 10.67% |
2018 | $4.80B | -0.33% |
2017 | $4.81B | 63.76% |
2016 | $2.94B | -24.11% |
2015 | $3.87B | 60.93% |
2014 | $2.41B | -6.23% |
2013 | $2.57B | 59.38% |
2012 | $1.61B | 1.72% |
2011 | $1.58B | 4.32% |
2010 | $1.52B | -11.31% |
2009 | $1.71B | -13.92% |
2008 | $1.99B | -0.32% |
2007 | $1.99B | 1.55% |
2006 | $1.96B | 3.80% |
2005 | $1.89B | 75.13% |
2004 | $1.08B | 51.12% |
2003 | $714.86M | 9.96% |
2002 | $650.09M | 10.01% |
2001 | $590.92M | - |